Vol 11, No 1: March 2014

Table of Contents


Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies PDF HTML
Liem Minh Phan, Sai-Ching Jim Yeung, Mong-Hong Lee 1-19
Mechanistic considerations for the use of monoclonal antibodies for cancer therapy PDF HTML
Patrick M. Glassman, Joseph P. Balthasar 20-33
pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment PDF HTML
Ke-Ni Yang, Chun-Qiu Zhang, Wei Wang, Paul C. Wang, Jian-Ping Zhou, Xing-Jie Liang 34-43

Original Article

Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention PDF HTML
Olga B. Garbuzenko, Gediminas Mainelis, Oleh Taratula, Tamara Minko 44-55
Uptake of prostate cancer screening and associated factors among Chinese men aged 50 or more: a population-based survey PDF HTML
Winnie K.W. So, Kai Chow Choi, Winnie P.Y. Tang, Paul C.W. Lee, Ann T.Y. Shiu, Simone S.M. Ho, Helen Y.L. Chan, Wendy W.T. Lam, William B. Goggins, Carmen W.H. Chan 56-63
Interferon-alpha-2b induces autophagy in hepatocellular carcinoma cells through Beclin1 pathway PDF HTML
Jun Zhao, Ming-Li Wang, Zeng Li, Dong-Mei Gao, Yu Cai, Jun Chang, Shi-Ping Wang 64-68